The cystic fibrosis transmembrane conductance regulator (CFTR) chloride channel, an ATP binding cassette (ABC) protein whose defects cause the deadly genetic disease cystic fibrosis (CF), encompasses two nucleotide binding domains (NBD1 and NBD2). Recent studies indicate that in the presence of ATP, the two NBDs coalesce into a dimer, trapping an ATP molecule in each of the two interfacial composite ATP binding sites (site 1 and site 2). Experimental evidence also suggests that CFTR gating is mainly controlled by ATP binding and hydrolysis in site 2, whereas site 1, which harbors several non-canonical substitutions in ATP-interacting motifs, is considered degenerated. The CF-associated mutation G551D, by introducing a bulky and negatively charged side chain into site 2, completely abolishes ATP-induced openings of CFTR. Here, we report a strategy to optimize site 1 for ATP binding by converting two amino acid residues to ABC consensus (i.e. H1348G) or more commonly seen residues in other ABC proteins (i.e. W401Y,W401F). Introducing either one or both of these mutations into G551D-CFTR confers ATP responsiveness for this disease-associated mutant channel. We further showed that the same maneuver also improved the function of WT-CFTR and the most common CFassociated ⌬F508 channels, both of which rely on site 2 for gating control. Thus, our results demonstrated that the degenerated site 1 can be rebuilt to complement or support site 2 for CFTR function. Possible approaches for developing CFTR potentiators targeting site 1 will be discussed.The CFTR 2 chloride channel belongs to the ATP binding cassette (ABC) proteins superfamily, whose members all share a basic architecture comprising two transmembrane domains and two cytoplasmic nucleotide binding domains (NBD1 and NBD2). Crystallographic studies have revealed that each NBD can be divided into a larger core (head) subdomain and a smaller helical (tail) subdomain; the former contains the conserved Walker motifs for binding and hydrolyzing ATP, whereas the latter is characterized by the signature motif (LSGGQ) unique to ABC proteins (1, 2). The two monomeric NBDs are so arranged that the head subdomain from one NBD faces the tail subdomain from the other NBD. Upon ATP binding, the NBDs assemble into a head-to-tail dimer connected by two ATP molecules at interfacial composite sites (site 1 and site 2, depicted in supplemental Fig. S1). This NBD dimer is subsequently destabilized when the enclosed ATP molecules are hydrolyzed.CFTR is classified as an asymmetric ABC protein (3, 4) as the constituents of its site 2 (i.e. NBD2 Walker motifs and NBD1 LSGGQ motif) retain all conserved residues, whereas those of its site 1 (i.e. NBD1 Walker motifs and NBD2 signature motif: LSHGH) present several non-consensus substitutions. Such a structural asymmetry is accompanied by the functional asymmetry that opening and closing of the CFTR pore located in transmembrane domains are controlled by ATP binding and hydrolysis, respectively, in the catalysis-competent site 2 (5, 6). This "...